CUSTOM ANTIBODY SERVICE MARKET ANALYSIS

Custom Antibody Service Market, by Service Type (Antibody Development, Antibody Production, Downstream Antibody Services, Others (Antibody Purification Services, Antibody Fragmentation and Conjugation and Others)), by Product Type (Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies), by Source (Rabbit, Chicken, Guinea pig, Goat, Mouse, Others (Rat and Others)), by Application (Oncology, Infectious diseases, Immunology, Neurobiology, Stem cells, Other (Cardiovascular Disease and Others)), by End Users (Pharmaceutical & biotechnology companies, Academic & research institutes, Contract research organizations), and by Region (North America, Europe, Asia Pacific, Middle East, Africa, and Latin America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Sep 2022
Code : CMI5254
Pages :227
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Companies covered:

Thermo Fisher Scientific, Inc., Genscript, Abcam plc., Cell Signaling Technology, Inc, Bio-Rad Laboratories, Inc., Merck KGaA, Agilent Technologies, Inc., BioLegend, Inc., ROCKLAND IMMUNOCHEMICALS, INC., ProMab, Innovagen AB, ProteoGenix, Bio-Techne., Creative Diagnostics., Sino Biological, Inc., RayBiotech Life, Inc., Abbiotec, Inc., ProSci Incorporated, Capralogics, Inc., and Boster Biological Technology

Custom Antibody Service Market Report Snapshots